Oncimmune
is an England-based biotechnology company that develops an analytical platform for the discovery of immunodiagnostic antibody biomarker signatures... Read moreOncimmune
is an England-based biotechnology company that develops an analytical platform for the discovery of immunodiagnostic antibody biomarker signatures... Read more
CEO
- -News
Mar 17, 2025
East Midlands Business LInk
Oncimmune: Precision medicine company falls into administration
Feb 24, 2025
Insider Media
Oncimmune: Oncimmune appoints advisers to help secure additional funding
Feb 10, 2025
Marketscreener
Oncimmune: Oncimmune forecasts 33% revenue growth in 2025 after doubling in 2024
Nov 01, 2024
Proactive Investors
Oncimmune: Oncimmune secures three new contracts, strengthening revenue pipeline and commercial momentum
Oct 18, 2024
Sharecast
Oncimmune: Oncimmune Holdings announces major recapitalisation
Sep 09, 2024
Sharecast
Oncimmune: Oncimmune shares surge on contract wins
May 24, 2024
Benzinga
Oncimmune: Oncimmune Reports Robust Interim Results, Exceeding Previous Year's Revenue in Just Six Months
May 23, 2024
Oncimmune Youtube Channel
Oncimmune posted a video "CEO, Martin Gouldstone, speaks to Vox Markets about the company's six month interim results." on YOUTUBE
May 14, 2024
Oncimmune Youtube Channel
Oncimmune posted a video "Oncimmune Scientists Decode Autoantibody Reactome Using xMAP Technology." on YOUTUBE
Apr 23, 2024
Outsourcing-Pharma
Oncimmune: Oncimmune setting its sights on the interplay between autoantibodies and age-related conditions
Oncimmune Competitors
1
2
3
4
5
6
7
8
9
10